Researchers have identified six key proteins that could be targeted to combat MS progression, and potential drugs that could ...

In an open letter, guest writer Rhonda Fuller tells her MS that she represents resilience, survival, and transformation.

MS relapse risk was low after age 60 whether patients continued or stopped DMTs, but MRI changes were more common than ...

Columnist Ben Hofmeister says being cool under fire came from good military training, but he wasn't prepared to manage the stress of MS.

An AI model predicted cognitive decline in MS with about 90% accuracy using brain scans, clinical data, and demographics.

Improved survival, rather than rising incidence, appears to be the main driver of increasing MS prevalence in France and ...

FDA clearance allows Imviva to test CTA313, an off-the-shelf CAR T-cell therapy, in progressive MS and other autoimmune ...

Among people with CIS, lower levels of certain small fatty molecules in the blood are associated with a higher relapse risk, ...

Columnist Desiree Lama says it takes so much effort to get through the day that she avoids most social activities these days.

Using the newer drug Briumvi versus Aubagio led to significantly better outcomes for treatment-naïve people with relapsing MS ...

Using the approved multiple sclerosis therapy Kesimpta helps keep relapsing MS stable over time for most adults, a real-world ...

PTSD is often associated with a single event, but for people with chronic illness, the trauma can be ongoing, says columnist Ben Hofmeister.